Compare Becton Dickinson and Co (BDX) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs GeneDx Holdings Corp — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $42.39B), while GeneDx Holdings Corp trades at $62.44 (market cap $1.89B). The key difference: Becton Dickinson and Co is far larger — about 22.4× GeneDx Holdings Corp's market cap, and Becton Dickinson and Co pays a 2.73% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| BDX | WGS | |
|---|---|---|
Market Cap | $42.39B | $1.89B |
Sector | Health | Technology |
52-Week High | $185.39 | $167.51 |
52-Week Low | $135.49 | $34.51 |
Enterprise Value | $58.85B | $1.89B |
Dividend Yield | 2.73% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
